A5028193665- Global Cancer Incidence and Screening
- Colorectal Cancer Screening and Detection
- Cancer Risks and Factors
- Economic and Financial Impacts of Cancer
- Multiple and Secondary Primary Cancers
- Health Systems, Economic Evaluations, Quality of Life
- BRCA gene mutations in cancer
- Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Esophageal Cancer Research and Treatment
- Thyroid Cancer Diagnosis and Treatment
- Pancreatic and Hepatic Oncology Research
- Bladder and Urothelial Cancer Treatments
- Ovarian cancer diagnosis and treatment
- AI in cancer detection
- Global Health Care Issues
- Immune Cell Function and Interaction
- Head and Neck Surgical Oncology
- Colorectal Cancer Surgical Treatments
- Parvovirus B19 Infection Studies
- Cancer Immunotherapy and Biomarkers
- HIV/AIDS drug development and treatment
- Genetic factors in colorectal cancer
- Legal and Labor Studies
- Artificial Intelligence in Healthcare
Istituti di Ricovero e Cura a Carattere Scientifico
2008-2022
Istituto Oncologico Veneto
2008-2022
Cancer Clinic
2021
Fondazione IRCCS Istituto Nazionale dei Tumori
2015-2017
Istituto Superiore di Sanità
2015-2017
Regione del Veneto
2000-2016
University of Lübeck
2015
Azienda Ospedaliera di Padova
2002-2005
Veneto Institute of Molecular Medicine
2001
University of Padua
1996
We have considered trends in incidence and mortality 28 European countries using data from successive volumes of Cancer Incidence Five Continents the WHO database. Countries with highest rates early 1960s included Nordic countries, Austria, Germany United Kingdom, but these areas tended to decline over recent calendar periods, particularly regard mortality. Southern showed upward trends, at least until 1980s for France Italy. Likewise, most central eastern ovarian cancer were originally...
This collaborative study, based on data collected by the network of Italian Cancer Registries (AIRTUM), describes burden rare cancers in Italy. Estimated number new cancer cases yearly diagnosed (incidence), proportion patients alive after diagnosis (survival), and estimated people still a (prevalence) are provided for about 200 different entities.Data herein presented were AIRTUM population- registries (CRs), covering nowadays 52% population. monograph uses database (January 2015), which...
Between 1992 and 1997, we conducted a case-control study of oesophageal cancer in 3 areas northern Italy. Cases were 275 men, ages 39–77 years (median age 60), with first incident squamous-cell carcinoma the oesophagus. Controls 593 36–77 60) admitted for acute illnesses, unrelated to tobacco alcohol, major hospitals under surveillance. Number daily cigarettes was strongly associated risk [odds ratio (OR) ≥25 cigarettes/day = 7.0)]. Long-duration smoking showed particularly elevated ORs (OR...
The effect of CC–chemokine receptor 5 (CCR5) promoter polymorphisms on the natural history human immunodeficiency virus (HIV) disease was studied in 73 HIV-1–infected children. CCR559338–59537 haplotype, CCR5-59029A/G polymorphism, and CCR5Δ32 CCR2-64I alterations were investigated. After exclusion carriers or CCR2-64I, Kaplan-Meier analysis disclosed that children with P1/P159353C,59356C,59402A genotype progressed faster to than did other haplotypes (P=.016). When included, this had...
PURPOSE: Assuring quality of care, while maintaining sustainability, in complex conditions such as breast cancer (BC) is an important challenge for health systems. Here, we describe a methodology to define set indicators, assess their computability from administrative data, and apply them large cohort BC cases. MATERIALS AND METHODS: Clinical professionals the Italian Regional Oncology Networks identified 46 clinically relevant indicators care; 22 were potentially computable using data....
Real-world (RW) evidence on nivolumab in pretreated patients with non-small cell lung cancer (NSCLC) by matching data from administrative health flows (AHFs) and clinical records (CRs) may close the gap between pivotal trials practice.This multicenter RW study aims at investigating median time to treatment discontinuation (mTTD), overall survival (mOS) of NSCLC both AHF CR; clinical-pathological features predictive early (etd), budget impact (BI), cost-effectiveness analysis were...
Background: In the Venetian Tumour Registry a substantial quota of cases (55%) is accepted using an algorithm that automatically evaluates diagnostic evidence: this study aims at assessing reliability information produced in way. Methods: A reabstraction was conducted, which put stratified sample 1539 through double-blind manual revision. Results: significantly higher proportion prevalent were found among breast, prostate and larynx cancer without microscopic confirmation, while there clear...
Objective: The impact of organized screening programs on breast cancer (BC) mortality is unclear in an era high spontaneous referral women to mammography. aim this study was analyze if the introduction mammographic reduced BC Veneto region, Italy, despite already widespread access Methods: In Veneto, introduced different years between 1999 and 2009 across 21 local health units (LHUs), inviting asymptomatic aged 50–69 undergo mammography biennially. We compared for 1995–2014 period 40–49...
Few studies deal with the association of socioeconomic and health system resource variables cancer survival at Italian regional level, where greatest number decisions about social policies allocations are taken. The present study aimed to describe causal relationships between factors compute expected provincial, area levels.Age-standardized relative 5 years from diagnosis cases incident in 1995-1998 followed up 2004 were derived by gender for 11 sites Association Cancer Registries data bank....
Promoting standardization and quality assurance (QA) may guarantee better outcomes for patients ensure a allocation of healthcare system resources. The present study tested the association between process indicators clinical pathway melanoma both patient short-term mortality budget utilization. Specific were selected to assess processes in different phases as well whole. Cox regression models run each phase test adherence indicator overall mortality. A Tobit analysis was used identify any...
Aims and background In Veneto a regional cancer registry has been operating since 1987 which provides incidence survival data for the region. It currently covers 48% of population. The aim this paper is to provide estimates incidence, mortality prevalence major cancers whole region in period 1970—2015. Methods were obtained by applying MIAMOD method, statistical back-calculation approach derive figures starting from relative data. Survival was modeled on basis published Italian registries....
In Veneto a regional cancer registry has been operating since 1987 which provides incidence and survival data for the region. It currently covers 48% of population. The aim this paper is to provide estimates incidence, mortality prevalence major cancers whole region in period 1970-2015.The were obtained by applying MIAMOD method, statistical back-calculation approach derive figures starting from relative data. Survival was modeled on basis published Italian registries.In 2012 most frequent...
Abstract Background: There are several options for cancer reduction in women with a BRCA 1-2 mutation, including prophylactic surgery, chemo-prevention and close surveillance. Each of these measures offers varying levels effectiveness mastectomy (PM) oophorectomy (PO) providing the greatest risk development breast ovarian cancer. The uptake preventive procedures, however, differs according to country, not only relation access care, but also cultural preferences. Here we present data on...
e18734 Background: The COVID-19 outbreak has had a huge impact on health care services worldwide. Previous studies projected delays in cancer diagnoses and excess mortality for patients as result of the pandemic. Little is known, however, pandemic functioning services. We aimed to fill this gap by using region-wide, population-based administrative data repository. Methods: obtained initiating targeted molecular therapy during 2017-2020 (January-September, quarter) Veneto. Eligible treatments...